Ordering
Available Variants5 mg
CHA.65829-5mg
Price
€93.16
Available – Dispatch in 14 days
25 mg
CHA.65829-25mg
Price
€435.20
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.65829-5mg | €93.16 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.65829-25mg | €435.20 |
≥98% (HPLC)
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C16H8Br2F6N6O |
|---|---|
| CAS Number | 426834-69-7 |
| Molecular Weight | 574.07 |
| NACRES | NA.77 |
| PubChem Substance ID | 329818416 |
| UNSPSC Code | 12352200 |
| MDL number | MFCD18432708 |
| Assay | ≥98% (HPLC) |
| Form | powder |
| Quality level | 100 |
Safety Information Handling visibility
| pictograms |
GHS06
 GHS06
|
|---|---|
| signalword | Danger |
| hcodes | H301,H413 |
| pcodes | P264 - P270 - P273 - P301 + P310 - P405 - P501 |
| Hazard Classifications | Acute Tox. 3 Oral - Aquatic Chronic 4 |
| Storage Class | 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
NS5806, also known by its CAS identifier 426834-69-7, is a synthetic compound that has garnered significant attention in the scientific community due to its unique pharmacological properties. Research has shown that NS5806 exhibits a high degree of selectivity and potency as a positive allosteric modulator of the AMPA receptor, a subtype of glutamate receptor that plays a crucial role in synaptic plasticity and neuronal excitability. The compounds ability to enhance AMPA receptor function has been implicated in its potential therapeutic applications, including the treatment of cognitive disorders and neurodegenerative diseases. Further studies are necessary to fully elucidate the mechanisms of action and potential clinical utility of NS5806, but its initial promise as a novel therapeutic agent is undeniable, warranting continued investigation and development.
